| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/19/2007 | US20070166328 Genetic immunization against cervical carcinoma |
| 07/19/2007 | US20070166327 Express chimeric anti-tumor receptors; cancer and autoimmune diseases eg lupus or rheumatoid arthritis |
| 07/19/2007 | US20070166326 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166325 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166324 West Nile vaccine |
| 07/19/2007 | US20070166323 Yeast-dendritic cell vaccines and uses thereof |
| 07/19/2007 | US20070166322 Adjuvant viral particle |
| 07/19/2007 | US20070166319 Human papilloma virus immunoreactive peptides |
| 07/19/2007 | US20070166318 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/19/2007 | US20070166317 Microparticles |
| 07/19/2007 | US20070166316 Tumor-derived biological antigen presenting particles |
| 07/19/2007 | US20070166315 Vibrio cholerae o139 conjugate vaccines |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | US20070166313 Administration of gamma globulins to treat cancer |
| 07/19/2007 | US20070166312 Antibody against tumor specific antigen as target |
| 07/19/2007 | US20070166311 Monoclonal antibody |
| 07/19/2007 | US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing |
| 07/19/2007 | US20070166309 Tumor necrosis factor receptor specific immunoglobulin for use in treatment and prevention of infection, autoimmune, inflammatory and cell proliferative disorders |
| 07/19/2007 | US20070166308 Monoclonal antibody specific to mucosal addressin cell adhesion molecule (MAdCAM) for use in prevention and treatment of inflammatory, gastrointestinal, liver disorders |
| 07/19/2007 | US20070166307 Suppression of transplant rejection |
| 07/19/2007 | US20070166306 Anti-CD19 antibody composition and method |
| 07/19/2007 | US20070166305 Human estrogen receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2007 | US20070166304 Method of Modulating the Activity of Functional Immune Molecules |
| 07/19/2007 | US20070166303 Ganglioside (GD3) specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2007 | US20070166302 Chemokine receptor-4 (CXCR4) specific immunoglobulin for diagnosis, prevention and treatment of viral or bacterial infection |
| 07/19/2007 | US20070166301 Method of Modulating the Activity of Functional Immune Molecules |
| 07/19/2007 | US20070166300 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains |
| 07/19/2007 | US20070166282 Homogeneous preparations of IL-28 and IL-29 |
| 07/19/2007 | US20070166281 Chloroquine coupled antibodies and other proteins with methods for their synthesis |
| 07/19/2007 | US20070166280 Chemokines as adjuvants of immune response |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | US20070166239 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | CA2640932A1 Methods for diagnosing and treating prostate cancer |
| 07/19/2007 | CA2636742A1 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor |
| 07/19/2007 | CA2636527A1 Viral hepatitis treatment |
| 07/19/2007 | CA2636149A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 07/19/2007 | CA2636032A1 Activation of hcv-specific t cells |
| 07/19/2007 | CA2635972A1 Chimeric and humanised anti-human il-13 antibodies |
| 07/19/2007 | CA2635724A1 Thermoreversible oil-in-water emulsion |
| 07/19/2007 | CA2633080A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | CA2632418A1 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | CA2632415A1 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | CA2630220A1 Norovirus and sapovirus antigens |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808490A2 Genetically engineered bleb vaccine |
| 07/18/2007 | EP1808489A1 Expression system for Bacillus anthracis PA |
| 07/18/2007 | EP1808446A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 07/18/2007 | EP1808443A1 Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI) |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808183A2 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1807508A2 Methods for preparing cells and viruses |
| 07/18/2007 | EP1807446A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 07/18/2007 | EP1807116A2 Influenza vaccination |
| 07/18/2007 | EP1807111A2 Respiratory syncytial virus (rsv) infection |
| 07/18/2007 | EP1807110A2 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 07/18/2007 | EP1807109A2 Enhancement of b cell proliferation by il-15 |
| 07/18/2007 | EP1807106A2 Compositions and methods for treating disease |
| 07/18/2007 | EP1806970A1 Milk production method |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1088077B1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 07/18/2007 | EP0981537B1 An infectious clone for human parainfluenza virus type 3 |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1327000C Shuttle vector of repeatable adenovirus of targeting melanoma and adenovirus |
| 07/18/2007 | CN1326998C Gene encoding hemagglutinin protein of H5 avian influenza virus and its application |
| 07/18/2007 | CN1326997C OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use |
| 07/18/2007 | CN1326881C Trivalent bispecific antibody and its preparation process and use |
| 07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
| 07/18/2007 | CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/18/2007 | CN1326878C Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application |
| 07/18/2007 | CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA) |
| 07/18/2007 | CN1326875C Tumor antigen protein and tumor antigen peptide |
| 07/18/2007 | CN1326874C SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
| 07/18/2007 | CN1326873C Vaccine for the prophylactic or therapeutic immunization against HIV |
| 07/18/2007 | CN1326567C Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 07/18/2007 | CN1326566C Immunotherapeutic combinations for the treatment of tumors |
| 07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
| 07/18/2007 | CN1326564C Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN101001880A Method of treating granuloma annulare or sarcoid |
| 07/18/2007 | CN101001876A Immunoglobulins comprising predominantly a GlcNacMAN5GLANAC2 glycoform |
| 07/18/2007 | CN101001875A Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 07/18/2007 | CN101001874A Poly-n-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
| 07/18/2007 | CN101001873A Variant fc regions |
| 07/18/2007 | CN101001872A Fcgamma-RIIB-specific antibodies and methods of use thereof |
| 07/18/2007 | CN101001869A Carcinoembryonic antigen fusions and uses thereof |
| 07/18/2007 | CN101001646A Stabilized synthetic immunogen delivery system |
| 07/18/2007 | CN101001645A Il-17 antagonistic antibodies |
| 07/18/2007 | CN101001642A Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors |
| 07/18/2007 | CN100998866A Preparation method of chicken coccidiosis fetra valence active vaccine composed from medicine sensitive insect plant |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244827 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
| 07/17/2007 | US7244819 Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244816 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorders |
| 07/17/2007 | US7244814 Variant Tat proteins and methods for use thereof |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244715 Vaccines containing ribavirin and methods of use thereof |